What stories should you be following in 2023? From India becoming the world’s most populous country, to an illegal drug that might be approved as a medicine, The Economist offers its annual look at the year ahead.
00:00 - The World Ahead 2023
00:35 - India's population potential
04:30 - Psychedelic medicines
08:06 - Japan’s markets mayhem?
12:45 - Repairing the world
15:50 - The coronation's colonial concerns
Read more on The World Ahead 2023: https://econ.st/3YyANzd
Read Tom Standage’s editor’s note on The World Ahead 2023: https://econ.st/3WM5wY3
Sign up to The Economist’s daily newsletter: https://econ.st/3QAawvI
Has China reached the peak of its powers? https://econ.st/3G3fgY8
India is continuing on its path to majoritarian chauvinism: https://econ.st/3jjZKOw
Will China’s economy ever overtake America’s in size? https://econ.st/3v0p0Mn
The Bank of Japan shocks investors: https://econ.st/3VkSbV8
Japan’s bond-market peg could snap: https://econ.st/3WiaVpT
Repairing clothes is becoming more fashionable: https://econ.st/3YJfCud
Ketamine, psilocybin and MDMA are coming to the medicine cabinet: https://econ.st/3W9G7aN
More American clinics are offering ketamine to treat depression: https://econ.st/3G3cBO3
Sensible policy on psychedelic drugs is growing more common: https://econ.st/3jeiak2
Psychedelic therapy shows great promise. More states should legalise it: https://econ.st/3V9pfj0
King Charles III’s coronation is a real marketing opportunity: https://econ.st/3BMcAf1